Why the study?
The council sought to formulate an expert opinion on the potential clinical use of a new fixed-dose combination of telmisartan and indapamide (modified-release tablets) in hypertensive patients.
An expert council formulated an opinion on the potential use of a novel fixed-dose combination of telmisartan and indapamide for treating hypertensive patients in the Russian Federation.
Expert consensus on telmisartan-indapamide FDC may inform hypertension options; leaves open randomized confirmation before practice change.
The aim of the expert council "First star duo of telmisartan and indapamide in the Russian Federation", dedicated to the introduction of a new fixed-dose combination of telmisartan and indapamide (modified-release tablets) into clinical practice was to formulate an expert opinion on the potential use of novel fixed-dose combination of telmisartan and indapamide in the treatment of hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Конради et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: